These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 11042226

  • 1. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

  • 2. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
    Rosati A, Decorti G, Klugmann FB, Candussio L, Granzotto M, Melato M, Giraldi T.
    Anticancer Res; 2000 Sep; 20(5B):3403-10. PubMed ID: 11131640
    [Abstract] [Full Text] [Related]

  • 3. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
    van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, Breimer DD.
    AIDS; 2001 Mar 09; 15(4):483-91. PubMed ID: 11242145
    [Abstract] [Full Text] [Related]

  • 4. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
    Zhu HJ, Wang JS, Donovan JL, Jiang Y, Gibson BB, DeVane CL, Markowitz JS.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):148-58. PubMed ID: 17963743
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport.
    Crivellato E, Candussio L, Rosati AM, Decorti G, Klugmann FB, Mallardi F.
    Histochem J; 1999 Oct 14; 31(10):635-43. PubMed ID: 10576412
    [Abstract] [Full Text] [Related]

  • 6. Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models.
    Taur JS, Rodriguez-Proteau R.
    Xenobiotica; 2008 Dec 14; 38(12):1536-50. PubMed ID: 18951251
    [Abstract] [Full Text] [Related]

  • 7. Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein.
    Iwai M, Minematsu T, Li Q, Iwatsubo T, Usui T.
    Drug Metab Dispos; 2011 Dec 14; 39(12):2314-20. PubMed ID: 21918035
    [Abstract] [Full Text] [Related]

  • 8. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K, Takara K, Tanigawara Y, Aoyama N, Kasuga M, Komada F, Sakaeda T, Okumura K.
    Jpn J Cancer Res; 1999 Dec 14; 90(12):1380-6. PubMed ID: 10665657
    [Abstract] [Full Text] [Related]

  • 9. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H, Higuchi M, Watanabe H, Koh Y, Ghosh AK, Mitsuya H, Tanoue N, Hamada A, Saito H.
    Biol Pharm Bull; 2009 Sep 14; 32(9):1588-93. PubMed ID: 19721237
    [Abstract] [Full Text] [Related]

  • 10. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R, Sun X, Deng YS, Qiu XW.
    Xenobiotica; 2019 Nov 14; 49(11):1373-1378. PubMed ID: 30587068
    [Abstract] [Full Text] [Related]

  • 11. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
    Hirsch-Ernst KI, Ziemann C, Rustenbeck I, Kahl GF.
    Toxicology; 2001 Oct 05; 167(1):47-57. PubMed ID: 11557129
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
    Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF.
    J Pharmacol Exp Ther; 2000 May 05; 293(2):376-82. PubMed ID: 10773005
    [Abstract] [Full Text] [Related]

  • 13. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.
    Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y.
    Drug Metab Pharmacokinet; 2008 May 05; 23(5):340-6. PubMed ID: 18974611
    [Abstract] [Full Text] [Related]

  • 14. Effect of ion-pair formation with bile salts on the in vitro cellular transport of berberine.
    Chae HW, Kim IW, Jin HE, Kim DD, Chung SJ, Shim CK.
    Arch Pharm Res; 2008 Jan 05; 31(1):103-10. PubMed ID: 18277615
    [Abstract] [Full Text] [Related]

  • 15. Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.
    Brimer C, Dalton JT, Zhu Z, Schuetz J, Yasuda K, Vanin E, Relling MV, Lu Y, Schuetz EG.
    Pharm Res; 2000 Jul 05; 17(7):803-10. PubMed ID: 10990198
    [Abstract] [Full Text] [Related]

  • 16. Is aspirin a substrate of MDR1/P-glycoprotein?
    Singh R, Naik T, Nigam A, Chatterjee S, Rajanna P, Shen H, Iyer R.
    Xenobiotica; 2020 Oct 05; 50(10):1258-1264. PubMed ID: 32302241
    [Abstract] [Full Text] [Related]

  • 17. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
    Endo T, Kimura O, Sakata M.
    Toxicol Appl Pharmacol; 2002 Dec 15; 185(3):166-71. PubMed ID: 12498733
    [Abstract] [Full Text] [Related]

  • 18. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.
    Sato S, Tohyama K, Kosugi Y.
    Eur J Pharm Sci; 2020 Jan 15; 142():105119. PubMed ID: 31682973
    [Abstract] [Full Text] [Related]

  • 19. MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.
    Fung KL, Pan J, Ohnuma S, Lund PE, Pixley JN, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM.
    Cancer Res; 2014 Jan 15; 74(2):598-608. PubMed ID: 24305879
    [Abstract] [Full Text] [Related]

  • 20. Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3).
    Florea BI, van der Sandt IC, Schrier SM, Kooiman K, Deryckere K, de Boer AG, Junginger HE, Borchard G.
    Br J Pharmacol; 2001 Dec 15; 134(7):1555-63. PubMed ID: 11724763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.